Literature DB >> 15121660

Early-stage face processing dysfunction in patients with schizophrenia.

Martin J Herrmann1, Heiner Ellgring, Andreas J Fallgatter.   

Abstract

OBJECTIVE: Deficits in emotional processing are evident in patients with schizophrenia. Since recent studies have indicated dysfunctions in cortical areas involved in face processing, this study investigated the early processing of faces in schizophrenia patients through the use of event-related potentials.
METHOD: Event-related potential responses were obtained from 24 schizophrenia patients and 28 healthy comparison subjects who were presented with pictures of faces and pictures of buildings (control stimuli).
RESULTS: Schizophrenia patients displayed significantly lower differences in the face-specific N170 component between the face and building pictures than did the healthy comparison subjects.
CONCLUSIONS: This finding suggests a dysfunction of early-stage visual processing of faces in patients with schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15121660     DOI: 10.1176/appi.ajp.161.5.915

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  34 in total

1.  Functional and structural deficits in brain regions subserving face perception in schizophrenia.

Authors:  Toshiaki Onitsuka; Margaret A Niznikiewicz; Kevin M Spencer; Melissa Frumin; Noriomi Kuroki; Lisa C Lucia; Martha E Shenton; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 2.  Deficits in Early Stages of Face Processing in Schizophrenia: A Systematic Review of the P100 Component.

Authors:  Holly A Earls; Tim Curran; Vijay Mittal
Journal:  Schizophr Bull       Date:  2015-07-14       Impact factor: 9.306

3.  Neutral face and complex object neurophysiological processing deficits in long-term schizophrenia and in first hospitalized schizophrenia-spectrum individuals.

Authors:  Dean F Salisbury; Jason W Krompinger; Spencer K Lynn; Toshiaki Onitsuka; Robert W McCarley
Journal:  Int J Psychophysiol       Date:  2019-06-04       Impact factor: 2.997

4.  Altered attentional and perceptual processes as indexed by N170 during gaze perception in schizophrenia: Relationship with perceived threat and paranoid delusions.

Authors:  Ivy F Tso; Anita M Calwas; Jinsoo Chun; Savanna A Mueller; Stephan F Taylor; Patricia J Deldin
Journal:  J Abnorm Psychol       Date:  2015-08

5.  Deficient cortical face-sensitive N170 responses and basic visual processing in schizophrenia.

Authors:  S Maher; Y Mashhoon; T Ekstrom; S Lukas; Y Chen
Journal:  Schizophr Res       Date:  2015-12-12       Impact factor: 4.939

6.  What's in a face? Effects of stimulus duration and inversion on face processing in schizophrenia.

Authors:  Pamela D Butler; Arielle Tambini; Galit Yovel; Maria Jalbrzikowski; Rachel Ziwich; Gail Silipo; Nancy Kanwisher; Daniel C Javitt
Journal:  Schizophr Res       Date:  2008-05-02       Impact factor: 4.939

7.  Attenuated modulation of the N170 ERP by facial expressions in schizophrenia.

Authors:  S K Lynn; D F Salisbury
Journal:  Clin EEG Neurosci       Date:  2008-04       Impact factor: 1.843

8.  Visual and associated affective processing of face information in schizophrenia: A selective review.

Authors:  Yue Chen; Tor Ekstrom
Journal:  Curr Psychiatry Rev       Date:  2015

9.  From neural signatures of emotional modulation to social cognition: individual differences in healthy volunteers and psychiatric participants.

Authors:  Agustín Ibáñez; Jaume Aguado; Sandra Baez; David Huepe; Vladimir Lopez; Rodrigo Ortega; Mariano Sigman; Ezequiel Mikulan; Alicia Lischinsky; Fernando Torrente; Marcelo Cetkovich; Teresa Torralva; Tristan Bekinschtein; Facundo Manes
Journal:  Soc Cogn Affect Neurosci       Date:  2013-05-17       Impact factor: 3.436

10.  Dysfunction in configural face processing in patients with schizophrenia.

Authors:  Yong-Wook Shin; Myung Hyon Na; Tae Hyon Ha; Do-Hyung Kang; So-Young Yoo; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2007-10-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.